Related references
Note: Only part of the references are listed.The relationship between leishmaniasis and AIDS: the second 10 years
Jorge Alvar et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response
Sudipta Bhowmick et al.
VACCINE (2007)
Leishmania donovani:: Identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis
R Garg et al.
VACCINE (2006)
Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen
R Polley et al.
INFECTION AND IMMUNITY (2006)
Leishmania vaccines: progress and problems
L. Kedzierski et al.
PARASITOLOGY (2006)
Immunologic memory in cutaneous leishmaniasis
P Scott
CELLULAR MICROBIOLOGY (2005)
Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro
S Dutta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis
M Breton et al.
INFECTION AND IMMUNITY (2005)
Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity
DG Brockstedt et al.
NATURE MEDICINE (2005)
Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection
KS Tabbara et al.
INFECTION AND IMMUNITY (2005)
Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation:: Evidence for mixed Th1-and Th2-like responses in visceral leishmaniasis
R Basu et al.
JOURNAL OF IMMUNOLOGY (2005)
Second-generation vaccines against leishmaniasis
RN Coler et al.
TRENDS IN PARASITOLOGY (2005)
Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani
R Garg et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response
JE Uzonna et al.
JOURNAL OF IMMUNOLOGY (2004)
Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis
RX Armijos et al.
VACCINE (2004)
Leishmaniasis: current situation and new perspectives
P Desjeux
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2004)
Recombinant Leishmania major secreting biologically active granulocyte-macrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice
C Dumas et al.
INFECTION AND IMMUNITY (2003)
Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous leishmaniasis but maintains its potency and durability
S Mendez et al.
INFECTION AND IMMUNITY (2003)
Persistence without pathology in phosphoglycan-deficient Leishmania major
GF Späth et al.
SCIENCE (2003)
The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts
GF Späth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Leishmania mexicana and Leishmania major:: Attenuation of wild-type parasites and vaccination with the attenuated lines
H Daneshvar et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and for photodynamic therapy
JF Sah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis
CJ Kelty et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2002)
Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination
B Papadopoulou et al.
INFECTION AND IMMUNITY (2002)
Drug resistance in Indian visceral leishmaniasis
S Sundar
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG
A Misra et al.
VACCINE (2001)
Leishmaniasis: Current status of vaccine development
E Handman
CLINICAL MICROBIOLOGY REVIEWS (2001)
The hamster as a model of human visceral leishmaniasis: Progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response
PC Melby et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
